# Opioid treatment program software that keeps methadone take home limits in front of the dosing window

> An opioid treatment program is a clinic certified under 42 CFR Part 8 to provide medications for opioid use disorder, including methadone and buprenorphine, together with counselling and related services. It must hold accreditation from an approved body, hold certification for a term not to exceed 3 years, and be registered with the DEA. Take home supply is capped at 7 days in the first 14 days of treatment, 14 days from day 15 and 28 days from day 31. Neurobird keeps the day count, the applicable ceiling and the documented rationale together.

- URL: https://neurobird.com/otpclinic/
- Product: Neurobird Opioid Treatment Program Methadone Compliance Platform
- Niche: opioid treatment program methadone
- Buyer: opioid treatment programs
- Status: in development, open for early access
- Updated: 2026-08-21

## What Neurobird Opioid Treatment Program Methadone does

- Track days in treatment per patient and surface the take home ceiling that applies today
- Capture the clinical rationale for each unsupervised dose decision at the point it is made
- Keep drug testing, counselling contacts and care plan reviews visible against the same patient timeline
- Assemble the evidence an accreditation survey asks for without pulling charts by hand

## How it works

1. **Count the days automatically** Admission date drives days in treatment, so the ceiling that applies today is shown rather than worked out.
2. **Capture the rationale where it happens** The criteria in 42 CFR 8.12 are on screen at the decision. The practitioner's reasoning is recorded once, into the clinical record.
3. **Make the survey a read** Take home decisions, drug testing, counselling contacts and care plan reviews sit on one timeline, so accreditation evidence is retrieved rather than reconstructed.

## From the source material

> Methadone is a long-acting synthetic opioid analgesic that works as a pharmacologic intervention for patients in drug treatment and detoxification programs.

Source: crimesolutions.ojp.gov, https://crimesolutions.ojp.gov/ratedpractices/methadone-maintenance-therapy

## Industry context

- **7, 14, 28** Take home supply beyond closed clinic days is limited to 7 days during the first 14 days of treatment, 14 days from day 15 and 28 days from day 31, with the practitioner deciding within each ceiling. (source: eCFR, 42 CFR 8.12, https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-8/subpart-C/section-8.12)
- **180 days** Interim treatment, where a patient receives some services while awaiting comprehensive treatment, is limited to 180 days and needs approval from both the Secretary and the state authority. (source: eCFR, 42 CFR Part 8, https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-8)
- **2024** The 2024 federal rule updated the treatment standards, including the take home framework, telehealth in initial evaluation and the definition of the diversion control plan. (source: Federal Register, Medications for the Treatment of Opioid Use Disorder, https://www.federalregister.gov/documents/2024/02/02/2024-01693/medications-for-the-treatment-of-opioid-use-disorder)
- **1301** An OTP must be registered with the DEA under 21 CFR 1301 before administering or dispensing medications for opioid use disorder, separately from SAMHSA certification. (source: eCFR, 21 CFR 1301, https://www.ecfr.gov/current/title-21/chapter-II/part-1301)
- **48 hours** Where an accreditation body finds severe non compliance that poses immediate risk, it must inform the program and the Secretary within 48 hours and report in writing within 5 business days. (source: DEA Diversion Control Division, https://www.deadiversion.usdoj.gov/)

## Pricing

- Single clinic: $320 per clinic, per month
- Program: $680 per clinic, per month
- Multi site: $1,200 per clinic, per month

## Questions

### What is an opioid treatment program?

An opioid treatment program, or OTP, is a clinic certified by SAMHSA under 42 CFR Part 8 to provide medications for opioid use disorder, including methadone and buprenorphine, alongside counselling and other services. To operate it must hold accreditation from an approved accrediting body, hold SAMHSA certification and be registered with the DEA.

### How long does OTP certification last?

Certification is granted for a term not to exceed 3 years, and accreditation bodies conduct routine surveys at least every 3 years so that certification can be renewed. A program that has not been certified before can receive provisional certification for up to 1 year while its accreditation is completed.

### What are the current take home rules for methadone?

Under 42 CFR 8.12 a patient may receive doses for days the clinic is closed regardless of time in treatment. Beyond that, the supply is limited to 7 days during the first 14 days of treatment, 14 days from day 15, and 28 days from day 31. Within each ceiling the decision sits with the practitioner, based on stated criteria, and the rationale must be documented in the clinical record.

### Is methadone treatment evidence based?

Yes. Methadone is an FDA approved medication for opioid use disorder and is dispensed in OTPs under federal treatment standards. The 2024 federal rule updated those standards, including the take home framework and the use of telehealth in initial evaluation, and the regulations set drug testing at no fewer than 8 random tests per patient per year.

### Does this replace our EHR?

No. It reads from it. The dosing history and admission dates come from your system, and the day counts, take home ceilings and rationale documentation live here where the nurse and the counselor can actually see them.

## Sources

- [eCFR, 42 CFR Part 8](https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-8)
- [eCFR, 42 CFR 8.12 treatment standards](https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-8/subpart-C/section-8.12)
- [Federal Register, Medications for the Treatment of Opioid Use Disorder](https://www.federalregister.gov/documents/2024/02/02/2024-01693/medications-for-the-treatment-of-opioid-use-disorder)
- [eCFR, 21 CFR 1301 DEA registration](https://www.ecfr.gov/current/title-21/chapter-II/part-1301)

## Contact

- office@neurobird.com
- https://neurobird.com/